Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Borrmann

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 3, 2010
Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphismTimothy Planche, Derek C Macallan, Toni Sobande, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from KenyaJohn Okombo, Steven M Kiara, Josea Rono, et al.
Plos One|December 24, 2010
Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural KenyaAlly Olotu, Gregory Fegan, Thomas N Williams, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1Leah Mwai, Steven M Kiara, Abdi Abdirahman, et al.
International Journal for Parasitology|February 7, 2007
Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitroDominik Burkhardt, Jochen Wiesner, Nicole Stoesser, et al.
The Journal of Infectious Diseases|March 28, 2003
Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malariaDenise P Mawili-Mboumba, Steffen Borrmann, David R Cavanagh, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 5, 2008
Lack of multiple copies of pfmdr1 gene in Papua New GuineaEva Maria Hodel, Jutta Marfurt, Dania Müller, et al.
Travel Medicine and Infectious Disease|December 16, 2022
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectivesJenny L Schnyder, Hanna K de Jong, Emmanuel B Bache, et al.
Malaria Journal|May 20, 2009
Chloroquine resistance before and after its withdrawal in KenyaLeah Mwai, Edwin Ochong, Abdi Abdirahman, et al.
The Journal of Infectious Diseases|February 21, 2004
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African childrenSteffen Borrmann, Ayola A Adegnika, Pierre-Blaise Matsiegui, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 3, 2010
Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphismTimothy Planche, Derek C Macallan, Toni Sobande, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from KenyaJohn Okombo, Steven M Kiara, Josea Rono, et al.
Plos One|December 24, 2010
Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural KenyaAlly Olotu, Gregory Fegan, Thomas N Williams, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1Leah Mwai, Steven M Kiara, Abdi Abdirahman, et al.
International Journal for Parasitology|February 7, 2007
Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitroDominik Burkhardt, Jochen Wiesner, Nicole Stoesser, et al.
The Journal of Infectious Diseases|March 28, 2003
Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malariaDenise P Mawili-Mboumba, Steffen Borrmann, David R Cavanagh, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 5, 2008
Lack of multiple copies of pfmdr1 gene in Papua New GuineaEva Maria Hodel, Jutta Marfurt, Dania Müller, et al.
Travel Medicine and Infectious Disease|December 16, 2022
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectivesJenny L Schnyder, Hanna K de Jong, Emmanuel B Bache, et al.
Malaria Journal|May 20, 2009
Chloroquine resistance before and after its withdrawal in KenyaLeah Mwai, Edwin Ochong, Abdi Abdirahman, et al.
The Journal of Infectious Diseases|February 21, 2004
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African childrenSteffen Borrmann, Ayola A Adegnika, Pierre-Blaise Matsiegui, et al.
Pageof 12